Literature DB >> 18723585

Missing pelvic inflammatory disease? Substantial differences in the rate at which doctors diagnose PID.

A Doxanakis1, R D Hayes, M Y Chen, L C Gurrin, J Hocking, C S Bradshaw, H Williams, C K Fairley.   

Abstract

OBJECTIVES: The clinical diagnosis of pelvic inflammatory disease (PID) is subjective. Our aim was to determine if the pattern of diagnosis of PID among experienced clinicians varied compared with the diagnosis of genital warts.
METHODS: We conducted a retrospective study of 325 PID diagnoses made by experienced clinicians at Melbourne Sexual Health Centre, Australia (2002-2006), where doctors saw 21 785 unselected female patients in a walk-in service. We compared the proportion of female patients diagnosed as having PID and genital warts between doctors and then compared doctors above (high diagnosing) and below (low diagnosing) the mean rate of PID diagnosis.
RESULTS: There were significant and clinically important differences in the proportion of women diagnosed with having PID (0-5.7%) across 23 doctors investigated. Estimated standard deviation in the frequency of PID diagnosis (logit scale) was 1.26 (95% CI 0.81 to 1.95)--approximately four times greater than for warts. Patients seen by high (n = 4673) and low (n = 16 787) diagnosing doctors had similar epidemiological risk profiles suggesting true distribution of PID cases across doctors was similar (p>0.13). Women diagnosed with having PID by high diagnosing doctors compared with low diagnosing doctors were younger (odds ratio 1.7; 95% CI 1.1 to 2.8, p = 0.013) but otherwise had similar epidemiological and clinical features.
CONCLUSIONS: Differences in diagnostic rates for PID between doctors are substantial and may be because of PID cases being missed by some doctors.

Entities:  

Mesh:

Year:  2008        PMID: 18723585     DOI: 10.1136/sti.2008.032318

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the United States, 1995 and 2006-2010.

Authors:  Jami S Leichliter; Anjani Chandra; Sevgi O Aral
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

2.  Management of first-episode pelvic inflammatory disease in primary care: results from a large UK primary care database.

Authors:  Amanda Nicholson; Greta Rait; Tarita Murray-Thomas; Gwenda Hughes; Catherine H Mercer; Jackie Cassell
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

Review 3.  Improving adherence to guidelines for the diagnosis and management of pelvic inflammatory disease: a systematic review.

Authors:  Bette Liu; Basil Donovan; Jane S Hocking; Janet Knox; Bronwyn Silver; Rebecca Guy
Journal:  Infect Dis Obstet Gynecol       Date:  2012-08-29

4.  Smoking, poor nutrition, and sexually transmitted infections associated with pelvic inflammatory disease in remote North Queensland Indigenous communities, 1998-2005.

Authors:  Ming Li; Robyn McDermott
Journal:  BMC Womens Health       Date:  2015-04-01       Impact factor: 2.809

5.  Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study.

Authors:  Helen Bittleston; Jane S Hocking; Jane L Goller; Jacqueline Coombe; Deborah Bateson; Sally Sweeney; Kirsteen Fleming; Wilhelmina M Huston
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.